石药集团抗肿瘤新药拟纳入突破性治疗品种,默沙东癌症1类新药在中国获批临床

医药经济报
21 Feb

西罗莫司(sirolimus)又称为雷帕霉素,是一种常用的特异性mTOR抑制剂。根据石药集团公开资料,该公司的注射用西罗莫司(白蛋白结合型)是采用特殊技术将西罗莫司包裹于人血白蛋白中,实现了西罗莫司的注射给药,且无需激素预处理,同时拓展了该药物的应用领域。西罗莫司是一种大环内酯抗生素类免疫抑制剂,为mTOR特异性抑制剂。mTOR是一类丝/苏氨酸激酶,细胞内存在mTORC1和mTORC2两种复合体,...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10